AbbVie submitted an application for risankizumab approval to the European Medicines Agency.

The entities involved

• AbbVie →

  pharmaceutical company

  • MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
  • AbbVie's product portfolio was bolstered by the acquisition of Allergan, while Humira sales faced erosion due to patent loss and biosimilar competition.Sun 13:48
• European Medicines Agency →

  highest regulatory authority on medicines in the European Union

  • IGC Pharma, Inc. is preparing data for potential U.S. FDA review and seeking EMA support for its lead drug candidate.Mon 14:18
  • Both the FDA and the European Medicines Agency are evaluating NervGen's lead therapeutic candidate.Fri 23:04

Related events

• Both the FDA and the European Medicines Agency govern drug approval processes.Aug 12
• The European Medicines Agency is seeking a positive opinion regarding the market access for a Pertuzumab biosimilar.Sep 21
• OS Therapies, Inc. is seeking regulatory approval from the European Medicines Agency for a new cancer treatment.Sep 15
• The FDA and European Medicines Agency are harmonizing regulatory review of drug applications.Sep 17
• INmune Bio Inc. submitted an Orphan Drug Designation and Scientific Advice package to the European Medicines Agency.Aug 26